全新好(000007.SZ)擬向武漢等地捐贈物資用於新型冠狀肺炎疫情防控
格隆匯2月2日丨全新好(000007.SZ)公佈,2020年春節期間,新型冠狀病毒疫情愈發嚴重,公司一方面做好自身防控工作,一方面積極踐行社會責任。為支持抗擊新型冠狀病毒,公司擬在未來兩個月內向武漢紅十字會及深圳慈善會等機構捐贈已獲得日本eleten株式會社專利授權生產的第二代滅菌紙巾20噸及消毒滅菌口罩100萬隻。
根據相關捐贈安排,目前已與武漢紅十字會及深圳慈善會取得聯繫並確認接收方式。第一批二代滅菌紙巾5噸(約800箱)已捐出,剩餘部分將於兩個月內捐出。消毒滅菌口罩公司正在積極聯繫相關生產商協商生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.